EP2650012
Meðhöndlun á blöðruhálskirtilskrabbameini á meinvarpsstigi með degarelixi
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
10.2.2009EP published:
25.3.2015EP application number:
13168404.5
EP translation filed:
20.5.2015Grant published:
15.6.2015EPO information:
European Patent Register
Max expiry date:
9.2.2029Expiry date:
9.2.2023
Title:
Treatment of metastatic stage prostate cancer with degarelix
Timeline
Today
10.2.2009EP application
25.3.2015EP Publication
20.5.2015Translation submitted
15.6.2015Registration published
9.2.2023Expires
Owner
Name:
Ferring B.V.Address:
Polaris Avenue 144, 2132, JX Hoofddorp, NL
Inventor
Name:
Persson, Bo-EricAddress:
St-Prex, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
27741 PDate:
11.2.2008Country:
US
Number:
08250703Date:
29.2.2008Country:
EP
Number:
147956 PDate:
28.1.2009Country:
US
Classification
Categories:
A61K 38/09, A61P 35/00, A61P 35/04
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 5.1.2016
Expires: 9.2.2017
Payer: Árnason Faktor
Number: 9
Paid: 9.1.2017
Expires: 9.2.2018
Payer: Árnason Faktor
Number: 10
Paid: 26.2.2018
Expires: 9.2.2019
Payer: Tego ehf.
Number: 11
Paid: 26.2.2019
Expires: 9.2.2020
Payer: Tego ehf.
Number: 12
Paid: 24.2.2020
Expires: 9.2.2021
Payer: Tego ehf.
Number: 13
Paid: 28.2.2021
Expires: 9.2.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 24.2.2022
Expires: 9.2.2023
Payer: Árnason Faktor ehf.